Have a personal or library account? Click to login

Side Effects of Long - Term Glucocorticoid Therapy: Case Report

Acta Medica Transilvanica
Volume 26 (2021): Issue 2 (June 2021)
By:
Open Access
|Aug 2021

References

  1. 1. Williams DM. Clinical Pharmacology of Corticosteroids. Respir Care. 2018;63(6):655-670.10.4187/respcare.0631429794202
    Search in Google ScholarBack to article
  2. 2. Alan IS, Alan B. Side Effects of Glucocorticoids. In: Malangu N, editor. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. London: IntechOpen; 2017. p. 93-124.10.5772/intechopen.72019
    Search in Google ScholarBack to article
  3. 3. Stanbury RM, Graham EM. Systemic corticosteroid therapy-side effects and their management. Br J Ophthalmol. 1998;82(6):704-8.10.1136/bjo.82.6.70417226229797677
    Search in Google ScholarBack to article
  4. 4. Hougardy DM, Peterson GM, Bleasel MD, Randall CT. Is enough attention being given to the adverse effects of corticosteroid therapy. Journal of Clinical Pharmacy and Therapeutics. 2000;25(3):227-234.10.1046/j.1365-2710.2000.00284.x10886467
    Search in Google ScholarBack to article
  5. 5. McDougall D, Bhibhatbhan A, Toth C. Adverse effects of corticosteroid therapy in neuromuscular diseased patients are common and receive insufficient prophylaxis. Acta Neurol Scand. 2009;120(5):364-7.10.1111/j.1600-0404.2009.01190.x19832774
    Search in Google ScholarBack to article
  6. 6. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14(1):2029-2049.10.2147/TCRM.S138000622590730464484
    Search in Google ScholarBack to article
  7. 7. Rees A, Levy M, Lansdown A. Clinical endocrinology and diabetes at a glance. 1st ed. Hoboken: Wiley; 2017.
    Search in Google ScholarBack to article
  8. 8. Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61(1):7-16.10.1007/s12020-018-1588-2599711629691807
    Search in Google ScholarBack to article
  9. 9. Sheu A, Diamond T. Bone mineral density: testing for osteoporosis. Australian prescriber. 2016;39(2):35-39.10.18773/austprescr.2016.020491763527340320
    Search in Google ScholarBack to article
  10. 10. WHO Scientific Group on the assessment of osteoporosis at primary health care level. Summary meeting report. Brussels: World Health Organization.; 2004. p.1-17.
    Search in Google ScholarBack to article
  11. 11. Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, Van K, Hyun D. Osteoporosis: A Review of Treatment Options. P T. 2018;43(2):92-104.
    Search in Google ScholarBack to article
  12. 12. Peng YL, Hu HY, Luo JC, Hou MC, Lin HC, Lee FY. Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study. Osteoporos Int. 2014;25(5):1617-23.10.1007/s00198-014-2647-z24566586
    Search in Google ScholarBack to article
  13. 13. Lindsay R, Krege JH, Marin F, Jin L, Stepan JJ. Teriparatide for osteoporosis: importance of the full course. Osteoporos Int. 2016;27(8):2395-410.10.1007/s00198-016-3534-6494711526902094
    Search in Google ScholarBack to article
  14. 14. Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007;357(20):2028-39.10.1056/NEJMoa071408
    Search in Google ScholarBack to article
  15. 15. Joseph RM, Hunter AL, Ray DW, Dixon WG. Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review. Semin Arthritis Rheum. 2016;46(1):133-41.10.1016/j.semarthrit.2016.03.001
    Search in Google ScholarBack to article
  16. 16. Ospina NS, Al Nofal A, Bancos I, Javed A, Benkhadra K, Kapoor E, Lteif AN, Natt N, Murad MH. ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2016 Fe;101(2):427-34.10.1210/jc.2015-1700
    Search in Google ScholarBack to article
  17. 17. Morris D. Steroid-induced diabetes and hyperglycaemia. Part 1: mechanisms and risks. Diabetes & Primary Care. 2018;20(4):151-3.
    Search in Google ScholarBack to article
  18. 18. Ginzler EM, Aranow C. 7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus. Baillière’s Clinical Rheumatology. 1998;12(3):495-510.10.1016/S0950-3579(98)80032-0
    Search in Google ScholarBack to article
  19. 19. Satyanarayanasetty D, Pawar K, Nadig P, Haran A. Multiple Adverse Effects of Systemic Corticosteroids: A Case Report. J Clin Diagn Res. 2015;9(5):FD01-2.
    Search in Google ScholarBack to article
  20. 20. Khurshid HF, Zikria S, Hamid S, Kumar VA. Self-Medication of Corticosteroids: A Life Threatening Case Report from Pakistan. Journal of Pharmacy Practice and Community Medicine. 2016;2(3):96-9.10.5530/jppcm.2016.3.7
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/amtsb-2021-0027 | Journal eISSN: 2285-7079 | Journal ISSN: 2285-7079
Journal RSS Feed
Language: English
Page range: 23 - 25
Submitted on: Apr 22, 2021
Accepted on: May 31, 2021
Published on: Aug 5, 2021
Published by: Lucian Blaga University of Sibiu
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
selfmedication,
glucocorticoids,
osteoporosis,
adrenal insufficiency
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2021 Ioana-Codruţa Lebădă, Elena Teodora Măerean, Roxana-Florina Inţă, published by Lucian Blaga University of Sibiu
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 26 (2021): Issue 2 (June 2021)Next article